Illumanations: The Future of Healthcare
Illumanations: The Future of Healthcare
Podcast Description
Welcome to Illumanations, the podcast where the brightest minds in biotech converge to ignite groundbreaking change. Join us as we delve into transformative ideas, explore the future of healthcare and highlight the exceptional talent driving the industry forward.
In each episode, we connect with trailblazers in platform therapeutics, diagnostics and medical devices — discovering what it takes to make life-changing drugs and technologies a reality.
Podcast Insights
Content Themes
The podcast focuses on topics like platform therapeutics, diagnostics, and medical devices, with episodes that delve into the transformative potential of cancer detection technologies and the complexities of developing life-changing drugs. For instance, discussions on early cancer detection emphasize the importance of team dynamics in biotech innovation.
Welcome to Illumanations, the podcast where the brightest minds in biotech converge to ignite groundbreaking change. Join us as we delve into transformative ideas, explore the future of healthcare and highlight the exceptional talent driving the industry forward.
In each episode, we connect with trailblazers in platform therapeutics, diagnostics and medical devices — discovering what it takes to make life-changing drugs and technologies a reality.
On this episode of IlLUMAnations, we turned inwards for the first time. Co-Founder and Partner of Luma Group, Themasap Khan, PhD, sits down with Neel Madhukar, PhD, Chief Technology Officer of Luma Group’s proprietary AI model, LABI, to discuss the genesis of the program and how it impacts day-to-day processes at Luma Group. Neel and Themasap discuss what we are building at Luma Group to change the game for biotech investing. LABI enables our investors to run deeper and more complex diligence processes, while simultaneously speeding up the process. Neel explains that LABI is an agentic system and therefore able to pull data, graphs, and research while connecting the concepts, allowing our investors to access all the information they need for diligence in minutes.
Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.